Axsome Therapeutics (AXSM) Other Gross PP&E Adjustments (2022 - 2025)
Axsome Therapeutics' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at -$20.9 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 287.48% year-over-year to -$20.9 million; the TTM value through Dec 2025 reached -$20.9 million, down 287.48%, while the annual FY2025 figure was -$20.9 million, 287.48% down from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$20.9 million at Axsome Therapeutics, up from -$23.3 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$384568.0 in Q3 2022 and bottomed at -$28.7 million in Q1 2025.
- The 4-year median for Other Gross PP&E Adjustments is -$8.0 million (2023), against an average of -$10.4 million.
- The largest annual shift saw Other Gross PP&E Adjustments crashed 2155.78% in 2023 before it grew 20.51% in 2024.
- A 4-year view of Other Gross PP&E Adjustments shows it stood at -$420000.0 in 2022, then plummeted by 1512.38% to -$6.8 million in 2023, then increased by 20.51% to -$5.4 million in 2024, then tumbled by 287.48% to -$20.9 million in 2025.
- Per Business Quant, the three most recent readings for AXSM's Other Gross PP&E Adjustments are -$20.9 million (Q4 2025), -$23.3 million (Q3 2025), and -$25.7 million (Q2 2025).